4.6 Review

Cancer in Transgender and Gender-Diverse Persons A Review

期刊

JAMA ONCOLOGY
卷 9, 期 4, 页码 556-563

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2022.7173

关键词

-

类别

向作者/读者索取更多资源

Transgender and gender-diverse individuals face unique challenges in cancer risk and outcomes due to barriers to health care access and inequities in treatment. Research shows a high prevalence of tobacco consumption, alcohol use, HPV and HIV infections among this population. These individuals are less likely to adhere to cancer screening programs and have a higher incidence of HIV- and HPV-associated cancers. A lack of knowledge among health care practitioners about the health needs of gender minorities and other barriers further hinder cancer prevention, care, and survivorship for transgender and gender-diverse individuals.
IMPORTANCE Transgender and gender-diverse individuals face unique challenges, including barriers to health care access and inequities in treatment, that may influence cancer risk and outcomes. OBSERVATIONS In this narrative review, a scoping review was conducted focusing on primary and secondary prevention and epidemiology of cancer, barriers to health care services, and health care practitioners' knowledge about specific issues pertaining to transgender and gender-diverse individuals. PubMed, the Cochrane Library, and Embase, were reviewed for citations from their inception to December 31, 2021. This review revealed that transgender and gender-diverse people had a high prevalence of tobacco consumption and alcohol use and high rates of infection with human papillomavirus (HPV) and HIV. Transgender and gender-diverse individuals were less likely to adhere to cancer screening programs and had a higher incidence of HIV-and HPV-associated cancers. Social and economic determinants seemed to drive these disparities in risk factors and outcomes. A lack of knowledge about gender minorities' health needs among health care practitioners was evidenced, and it represented a major hurdle to cancer prevention, care, and survivorship for transgender and gender-diverse individuals. Discrimination, discomfort caused by gender-labeled oncological services, stigma, and lack of cultural sensitivity of health care practitioners were other barriers met by transgender and gender-diverse persons in the oncology setting.CONCLUSIONS AND RELEVANCE The findings suggest that transgender and gender-diverse peoples' needs in the cancer care continuum are not optimally addressed. Effective solutions are needed to offer the best care to every patient in a person-centric and gender diversity-sensitive environment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据